Advanced Imaging

AdvancedImagingPro.com

   

Industry News

Updated: July 8th, 2008 05:26 PM CDT

Cytogen and Philips Demonstrate PROSTASCINT(R) Image Acquisition and Processing Tools That Improve Efficiency and Reduce Imaging Time

Advertisement
via PRNewswire

ABOUT ROYAL PHILIPS ELECTRONICS

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is oneof the world's biggest electronics companies and Europe's largest, with salesof $37.7 billion (EUR 30.4 billion) in 2005. With activities in the threeinterlocking domains of healthcare, lifestyle and technology and 161,500employees in more than 60 countries, it has market leadership positions inmedical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions. News from Philips islocated at http://www.philips.com/newscenter.

This press release contains certain "forward-looking" statements withinthe meaning of the Private Securities Litigation Reform Act of 1995 andSection 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, included in this pressrelease regarding our strategy, future operations, financial position, futurerevenues, projected costs, prospects, plans and objectives of management areforward-looking statements. Such forward-looking statements involve a numberof risks and uncertainties and investors are cautioned not to put any unduereliance on any forward-looking statement. There are a number of important factors that could cause Cytogen's results to differ materially from thoseindicated by such forward-looking statements. In particular, Cytogen'sbusiness is subject to a number of significant risks, which include, but arenot limited to: the risk of obtaining additional capital; the risk ofobtaining the necessary regulatory approvals; the risk of whether productsresult from development activities; the risk of shifts in the regulatory environment affecting sales of Cytogen's products such as third-party payor reimbursement issues; the risk associated with Cytogen's dependence on itspartners for development of certain projects, as well as other factorsexpressed from time to time in Cytogen's periodic filings with the Securitiesand Exchange Commission (the "SEC"). As a result, this press release shouldbe read in conjunction with Cytogen's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date ofthis press release, and Cytogen undertakes no obligation to publicly updatesuch forward-looking statements to reflect subsequent events or circumstances.

SOURCE Cytogen Corporation; Royal Philips Electronics


News stories provided by third parties are not edited by "Site Publication" staff. For suggestions and comments, please click the Contact link at the bottom of this page.


Subscribe to our RSS Feeds